Nextleaf Solutions Ltd. specializes in cannabis extraction technology, focusing on the development and licensing of cannabinoid extraction and formulation processes. While the company has a reasonable gross margin of 38%, it faces significant concerns with negative EBITDA and net margins, indicating ongoing operational losses. The current ratio of 1.48 suggests adequate liquidity, but the quick ratio of 0.50 raises concerns about immediate cash availability. The stock's recent 20% drop may reflect market apprehension, despite its niche position in a growing industry.
Loading financial metrics...
Revenue fell 16.1% year-over-year from $12.3M to $10.3M. The decline has persisted for multiple quarters.
Company posted a loss of $-1.4M over the last year, representing 13.9% of revenue.
Strong balance sheet with net cash position provides cushion for growth investments.
Low debt-to-revenue ratio of 4.1% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (March 31, 2026)